Finance

Lists
1789:TPE
ScinoPharm Taiwan Ltd
NT$19.70
+0.25%
(+0.050) 1D
Nov 13, 1:30:23 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1789...
Open
NT$19.65
High
NT$20.05
Low
NT$19.50
Mkt. cap
15.58B
Avg. vol.
618.02K
Volume
568.39K
Dividend
1.47%
Quarterly dividend
NT$0.07
Ex-dividend date
Jul 2, 2026
P/E ratio
414.04
52-wk high
NT$29.10
52-wk low
NT$16.70
EPS
NT$0.05
Shares outstanding
790.74M
No. of employees
1K
Open
NT$19.65
High
NT$20.05
Low
NT$19.50
Mkt. cap
15.58B
Avg. vol.
618.02K
Volume
568.39K
Dividend
1.47%
Quarterly dividend
NT$0.07
Ex-dividend date
Jul 2, 2026
P/E ratio
414.04
52-wk high
NT$29.10
52-wk low
NT$16.70
EPS
NT$0.05
Shares outstanding
790.74M
No. of employees
1K
News stories
From web sources and news partners
About ScinoPharm Taiwan Ltd
CEO-
Employees1.01K
FoundedNov 11, 1997
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitescinopharm.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.01B
659.71M
678.50M
694.09M
Cost of goods sold
674.97M
438.17M
543.87M
546.02M
Cost of revenue
674.97M
438.17M
543.87M
546.02M
Research and development expenses
195.17M
85.54M
86.45M
93.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
128.12M
112.89M
113.74M
116.98M
Operating expense
325.04M
213.05M
200.04M
210.71M
Total operating expenses
1.00B
651.22M
743.91M
756.73M
Operating income
8.03M
8.49M
-65.41M
-62.64M
Other non operating income
19.92M
-7.76M
3.85M
34.83M
EBT including unusual items
23.96M
19.32M
-53.50M
-16.93M
EBT excluding unusual items
21.96M
19.35M
-53.42M
-16.93M
Income tax expense
-17.32M
2.80M
-17.98M
-11.35M
Effective tax rate
-72.27%
14.47%
33.60%
67.07%
Other operating expenses
-
-
-
-
Net income
41.28M
16.53M
-35.53M
-5.57M
Net profit margin
4.10%
2.51%
-5.24%
-0.80%
Earnings per share
0.05
-
-
-
Interest and investment income
-
13.03M
14.10M
14.14M
Interest expense
-16.12M
-2.97M
-3.06M
-3.26M
Net interest expenses
-16.12M
10.06M
11.05M
10.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
134.08M
133.63M
55.46M
74.68M
Gain or loss from assets sale
188.00K
21.00K
88.00K
61.00K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps